| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 03/08/2005 | US6863647 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 03/03/2005 | WO2005019396A1 Reactions products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidazoles with epoxides as lubricant additives |
| 03/03/2005 | WO2005019212A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 03/03/2005 | WO2005019192A1 Urea derivatives and their use as tyrosinkinase inhibitors |
| 03/03/2005 | WO2005019184A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 03/03/2005 | WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/03/2005 | WO2005019161A1 Cathepsin cysteine protease inhibitors |
| 03/03/2005 | WO2005019151A1 Ppar modulators |
| 03/03/2005 | WO2005003098B1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents |
| 03/03/2005 | WO2005000309A3 Chemical compounds |
| 03/03/2005 | WO2005000298A3 5-membered heterocycle-based p-38 inhibitors |
| 03/03/2005 | WO2004110350A3 Compouds and uses thereof in modulating amyloid beta |
| 03/03/2005 | WO2004092119A3 Method for producing alpha-methylated cysteine and serine derivatives |
| 03/03/2005 | WO2003089418A8 Indane acetic acid derivatives and their use as pharmaceutical agents |
| 03/03/2005 | US20050049376 High refractive index, uv-curable monomers and coating compositions prepared therefrom |
| 03/03/2005 | US20050049325 Photopolymerization of acrylated ester |
| 03/03/2005 | US20050049258 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 03/03/2005 | US20050049254 Substituted heterocyclic compounds |
| 03/03/2005 | US20050049244 osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis |
| 03/03/2005 | DE10336186A1 Sulfonamid-Anionen als Katalysatoren für die NCO-Oligomerisierung Sulfonamide anions as catalysts for the NCO oligomerization |
| 03/03/2005 | CA2536089A1 Ppar modulators |
| 03/03/2005 | CA2535359A1 Cathepsin cysteine protease inhibitors |
| 03/03/2005 | CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/02/2005 | EP1510515A1 Phenylglycine derivatives as serine protease inhibitors |
| 03/02/2005 | EP1509509A1 Glucagon antagonists/inverse agonists |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509213A2 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/02/2005 | EP1509188A2 Compounds active at the glucocorticoid receptor ii |
| 03/02/2005 | EP1129084B1 Thiazole derivatives as ppar gamma ligands |
| 03/02/2005 | EP0991636B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/02/2005 | EP0871448B1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase |
| 03/02/2005 | CN1191240C Nitrogen monoxide synthase inhibitor, its preparation method and application |
| 03/02/2005 | CN1191015C Method for preventing and controlling termites |
| 03/01/2005 | US6861532 Synthesis of 2-alkylcysteine |
| 03/01/2005 | US6861522 Process for the manufacture of thiazole derivatives with pesticidal activity |
| 02/24/2005 | WO2005017037A1 Sulphonamide anions as catalysts for nco oligomerisation |
| 02/24/2005 | WO2005016915A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators |
| 02/24/2005 | WO2005016888A1 Probe for diseases wth amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016384A1 Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change |
| 02/24/2005 | WO2004099168A3 Substituted carboxylic acids |
| 02/24/2005 | WO2004094395A3 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers |
| 02/24/2005 | WO2004066964A3 Amino acid phenoxy ethers |
| 02/24/2005 | WO2004010997A8 Sustained-release tablet composition of pramipexole |
| 02/24/2005 | US20050043523 Benzothiazole derivative compounds, compositions and uses |
| 02/24/2005 | US20050043397 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/24/2005 | US20050043379 Leukotriene hydrolase inhibitors; antiinflammatory agents; antihistamines; chronic onstructive pulmonary disorders; atherosclerosis; multiple sclerosis; inflammatory bowel disorders; antiarthritic agents ;psoriasis |
| 02/24/2005 | US20050043378 LTA4H modulators |
| 02/24/2005 | US20050043377 Thioflavin derivatives for use in the antemortem diagnosis of alzheimers disease and in vivo imaging and prevention of amyloid deposition |
| 02/24/2005 | US20050043376 Epothilone A and B; desoxyepothilone A and B; anticancer agenst |
| 02/24/2005 | US20050043358 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 02/24/2005 | US20050043307 Novel heterocycle as agonist or antagonist for nervous systems which can contain double or triple bonds with nitrogen, oxygen or sulfur with carbon or azo groups and or salts and as modulators or receptors with carriers |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050042407 containing a cyanovinylene group; can be written on or read by blue light, preferably laser light |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2534850A1 Sulphonamide anions as catalysts for nco oligomerisation |
| 02/24/2005 | CA2500358A1 Probes for diseases in which amyloid accumulates, agents for staining amyloid, drugs for treatment and prophylaxis of diseases with accumulated amyloid, and probes for diagnosis of neurofibrillary tangles and agents for staining neurofibrillary tangles |
| 02/23/2005 | EP1507772A1 Methods of using thiazolidinedithione derivatives |
| 02/23/2005 | EP1507530A1 Diaminothiazoles |
| 02/23/2005 | EP0883612B1 Thiol derivatives with metallopeptidase (ace/nep) inhibitory activity |
| 02/23/2005 | CN1585758A A process for the preparation of cephalosporins side chains |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585745A Hydroxyfattysulfonic acid analogs |
| 02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
| 02/23/2005 | CN1585639A Antimalarial agents |
| 02/23/2005 | CN1585638A Linked biaryl compounds |
| 02/23/2005 | CN1190434C Novel heterocyclic compounds and process for its preparation, and pharmaceutical compositions containing them and their use in treatment of diabetes and related diseases |
| 02/23/2005 | CN1190429C Method for producing z-chloro-5-chloromethyl-1,3-thiazole |
| 02/22/2005 | US6858737 Process for producing 2-cyanoimino-1,3-thiazolidine |
| 02/22/2005 | US6858639 3-Arylphenyl sulfide derivative and insecticide and miticide |
| 02/22/2005 | US6858633 Substituted 2-arylbenzazole compounds and their use as antitumour agents |
| 02/22/2005 | US6858411 Recombinant nucleic acids that encode epothilone polyketide synthase (PKS) are used to express recombinant PKS genes in host cells to produce epothilone derivatives/polyketides; used as cancer drugs, fungicides and immunosuppressants |
| 02/22/2005 | CA2438032A1 Benzothiazole derivative compounds, compositions and uses |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/17/2005 | WO2005014592A1 2-amino-5-benzoylthiazole npy antagonists |
| 02/17/2005 | WO2005014591A1 2-acylamino or 2-sulfonylamino-1, 3-thiazoles as couplers for the oxidation dyeing of keratin fibres |
| 02/17/2005 | WO2005014562A1 Pramipexole acid addition salts |
| 02/17/2005 | WO2005014561A1 Compounds having thrombopoietin receptor agonism |
| 02/17/2005 | WO2005014525A2 Bi-aryl compound having immunosuppressive activity |
| 02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | WO2004016578A8 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 02/17/2005 | WO2004002491A8 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 02/17/2005 | US20050038260 Intermediate for biotin and process for producing the same |
| 02/17/2005 | US20050038259 Elastase release inhibitors; such as 19-(1H-tetrazol-5-yl)nonadec-6-en-5-ol |
| 02/17/2005 | US20050038112 prevention, control and treatment of cancer; leukemia |
| 02/17/2005 | US20050038098 Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseases |
| 02/17/2005 | US20050038089 Thiazole derivatives |
| 02/17/2005 | US20050038087 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 02/17/2005 | US20050038082 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization |
| 02/17/2005 | US20050038081 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide |
| 02/17/2005 | US20050038051 Novel molecules for regulating cell death |
| 02/17/2005 | US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 02/17/2005 | US20050038020 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods |
| 02/17/2005 | US20050038014 5'-carbamoyl-1,1' biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 02/17/2005 | US20050037997 Detoxification; hydrolases or esterases; short half-life; non-insulin dependent diabetes; side effect reduction |
| 02/17/2005 | US20050037931 Reaction products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidazoles with epoxides as lubricant additives |
| 02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | CA2533463A1 2-amino-5-benzoylthiazole npy antagonists |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |